Virtual Medicinal Product (VMP) - Diphtheria / Tetanus / Pertussis (acellular component) / Poliomyelitis (inactivated) / Haemophilus type b conjugate vaccine (adsorbed) suspension for injection 0.5ml vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Diphtheria / Tetanus / Pertussis (acellular component) / Poliomyelitis (inactivated) / Haemophilus type b conjugate vaccine (adsorbed) suspension for injection 0.5ml vials Start Date 27-04-2006 End Date
Previous Name Previous Name Diphtheria / Tetanus / Pertussis / Poliomyelitis (inactivated) / Haemophilus type b conjugate vaccine (adsorbed) suspension for injection 0.5ml vials Start Date 15-09-2004 End Date 26-04-2006
Abbreviated Name Abbreviated Name DTaP/IPV/Hib conj vacc (ads) inj 0.5ml vials Start Date 01-05-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
0.5
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Suspension for injection
Ontology Form/Route
suspensioninjection.intramuscular
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
J07CA06
BNF Start Date End Date
Current BNF 14040000 Start Date 04-04-2022 End Date
Previous BNF 14040000 Start Date 07-04-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
8100611000001109 15-09-2004

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Diphtheria toxoid
Haemophilus influenzae type b polysaccharide protein conjugate
Human poliovirus type 1 inactivated
Human poliovirus type 2 inactivated
Human poliovirus type 3 inactivated
Pertussis antigens
Tetanus toxoid

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial